{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:48:04Z","timestamp":1789501684934,"version":"build-2803163510"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11033-019-05167-x","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T11:19:06Z","timestamp":1572607146000},"page":"819-841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9922-7181","authenticated-orcid":false,"given":"Reza","family":"Nedaeinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibollah","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh Haghjooye","family":"Javanmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ghayour-Mobarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Goli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baratali","family":"Mashkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhdeh","family":"Nedaeinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein Hayavi","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"issue":"4","key":"5167_CR1","first-page":"319","volume":"11","author":"MH Periayah","year":"2017","unstructured":"Periayah MH, Halim AS, Mat Saad AZ (2017) Mechanism action of platelets and crucial blood coagulation pathways in hemostasis. Int J Hematol Oncol Stem Cell Res. 11(4):319\u2013327","journal-title":"Int J Hematol Oncol Stem Cell Res."},{"issue":"11","key":"5167_CR2","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","volume":"34","author":"GE Raskob","year":"2014","unstructured":"Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ et al (2014) Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 34(11):2363\u20132371","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"39","key":"5167_CR3","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1093\/eurheartj\/eht356","volume":"34","author":"M Nichols","year":"2013","unstructured":"Nichols M, Townsend N, Scarborough P, Rayner M (2013) Cardiovascular disease in Europe: epidemiological update. Eur Heart J 34(39):3028\u20133034","journal-title":"Eur Heart J"},{"issue":"2","key":"5167_CR4","first-page":"28","volume":"2","author":"SR Kotra","year":"2013","unstructured":"Kotra SR, Peravali B, Kumar A, Pulicherla K (2013) Staphylokinase: a boon in medical sciences\u2013review. M J Pharm Med Sci 2(2):28\u201334","journal-title":"M J Pharm Med Sci"},{"key":"5167_CR5","volume-title":"Tobacco use and the risk of cardiovascular diseases in developed and developing countries","author":"M Alexander","year":"2013","unstructured":"Alexander M (2013) Tobacco use and the risk of cardiovascular diseases in developed and developing countries. University of Cambridge, Cambridge"},{"key":"5167_CR6","doi-asserted-by":"crossref","first-page":"297305","DOI":"10.1155\/2013\/297305","volume":"2013","author":"K Pulicherla","year":"2013","unstructured":"Pulicherla K, Kumar A, Gadupudi G, Kotra SR, Sambasiva Rao K (2013) In vitro characterization of a multifunctional staphylokinase variant with reduced reocclusion, produced from salt inducible E. coli GJ1158. BioMed Res Int 2013:297305","journal-title":"BioMed Res Int"},{"issue":"1","key":"5167_CR7","first-page":"41","volume":"56","author":"M Kowalski","year":"2009","unstructured":"Kowalski M, Brown G, Bieniasz M, Oszajca K, Chabielska E, Pietras T et al (2009) Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent\u2013a staphylokinase variant. Acta Biochim Pol 56(1):41","journal-title":"Acta Biochim Pol"},{"issue":"18","key":"5167_CR8","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.jacc.2014.01.069","volume":"63","author":"WJ Kikkert","year":"2014","unstructured":"Kikkert WJ, van Geloven N, van der Laan MH, Vis MM, Baan J, Koch KT et al (2014) The prognostic value of Bleeding Academic Research Consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications. J Am Coll Cardiol 63(18):1866\u20131875","journal-title":"J Am Coll Cardiol"},{"key":"5167_CR9","unstructured":"Kumar A, Pulicherla K, Ram KS, Rao K (2010) Evolutionary trend of thrombolytics. Int J Bio-sci Bio-technol 2(4):51\u201368"},{"issue":"1","key":"5167_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/act.2012.18101","volume":"18","author":"C Ulbricht","year":"2012","unstructured":"Ulbricht C (2012) Peripheral vascular disease: an integrative approach: a natural standard monograph. Altern Complement Ther 18(1):44\u201350","journal-title":"Altern Complement Ther"},{"issue":"3","key":"5167_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pathophys.2009.12.001","volume":"17","author":"P Deb","year":"2010","unstructured":"Deb P, Sharma S, Hassan K (2010) Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 17(3):197\u2013218","journal-title":"Pathophysiology"},{"issue":"4","key":"5167_CR12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pneurobio.2010.08.001","volume":"92","author":"J Wang","year":"2010","unstructured":"Wang J (2010) Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 92(4):463\u2013477","journal-title":"Prog Neurobiol"},{"issue":"3","key":"5167_CR13","first-page":"318","volume":"34","author":"N Sikri","year":"2007","unstructured":"Sikri N, Bardia A (2007) A history of streptokinase use in acute myocardial infarction. Tex Heart Inst J 34(3):318","journal-title":"Tex Heart Inst J"},{"issue":"1","key":"5167_CR14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/01.CIR.89.1.432","volume":"89","author":"RL Mueller","year":"1994","unstructured":"Mueller RL, Scheidt S (1994) History of drugs for thrombotic disease. Discovery, development, and directions for the future. Circulation 89(1):432\u2013449","journal-title":"Circulation"},{"issue":"1","key":"5167_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/157489008783331670","volume":"3","author":"A Kunamneni","year":"2008","unstructured":"Kunamneni A, Ravuri BD, Saisha V, Ellaiah P, Prabhakhar T (2008) Urokinase-a very popular cardiovascular agent. Recent Pat Cardiovasc Drug Discovery 3(1):45\u201358","journal-title":"Recent Pat Cardiovasc Drug Discovery"},{"key":"5167_CR16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-3002(57)90194-4","volume":"24","author":"J Ploug","year":"1957","unstructured":"Ploug J, Kjeldgaard NO (1957) Urokinase an activator of plasminogen from human urine I. Isolation and properties. Biochim Biophys Acta 24:278\u2013282","journal-title":"Isolation and properties. Biochim Biophys Acta"},{"issue":"4\u20136","key":"5167_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000215814","volume":"18","author":"VW van Hinsbergh","year":"1988","unstructured":"van Hinsbergh VW (1988) Regulation of the synthesis and secretion of plasminogen activators by endothelial cells. Pathophysiol Haemost Thromb 18(4\u20136):307\u2013327","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"2","key":"5167_CR18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0021-9258(19)35456-0","volume":"263","author":"G Larsen","year":"1988","unstructured":"Larsen G, Henson K, Blue Y (1988) Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and\/or the epidermal growth factor domains. J Biol Chem 263(2):1023\u20131029","journal-title":"J Biol Chem"},{"issue":"51","key":"5167_CR19","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1021\/bi001847a","volume":"39","author":"S Yakovlev","year":"2000","unstructured":"Yakovlev S, Makogonenko E, Kurochkina N, Nieuwenhuizen W, Ingham K, Medved L (2000) Conversion of fibrinogen to fibrin: mechanism of exposure of tPA-and plasminogen-binding sites. Biochemistry 39(51):15730\u201315741","journal-title":"Biochemistry"},{"issue":"4","key":"5167_CR20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.STR.0000064841.47697.22","volume":"34","author":"HP Adams","year":"2003","unstructured":"Adams HP, Adams RJ, Brott T, Del Zoppo GJ, Furlan A, Goldstein LB et al (2003) Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 34(4):1056\u20131083","journal-title":"Stroke"},{"issue":"20","key":"5167_CR21","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1161\/CIRCULATIONAHA.107.181486","volume":"115","author":"HP Adams","year":"2007","unstructured":"Adams HP, Del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A et al (2007) Guidelines for the early management of adults with ischemic stroke. Circulation 115(20):e478\u2013e534","journal-title":"Circulation"},{"issue":"1","key":"5167_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2005.09.003","volume":"44","author":"DB Baruah","year":"2006","unstructured":"Baruah DB, Dash RN, Chaudhari M, Kadam S (2006) Plasminogen activators: a comparison. Vascul Pharmacol 44(1):1\u20139","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"5167_CR23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/oxfordjournals.jbchem.a124404","volume":"115","author":"H Shibata","year":"1994","unstructured":"Shibata H, Nagaoka M, Sakai M, Sawada H, Watanabe T, Yokokura T (1994) Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex. J Biochem 115(4):738\u2013742","journal-title":"J Biochem"},{"issue":"11","key":"5167_CR24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/heart.89.11.1358","volume":"89","author":"TK Nordt","year":"2003","unstructured":"Nordt TK, Bode C (2003) Thrombolysis: newer thrombolytic agents and their role in clinical medicine. Heart 89(11):1358\u20131362","journal-title":"Heart"},{"issue":"2","key":"5167_CR25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/1574890110999150202150017","volume":"9","author":"A Kunamneni","year":"2014","unstructured":"Kunamneni A, Durvasula R (2014) Streptokinase-a drug for thrombolytic therapy: a patent review. Recent Pat Cardiovasc Drug Discov 9(2):106\u2013121","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"issue":"5761","key":"5167_CR26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1121143","volume":"311","author":"Q Huai","year":"2006","unstructured":"Huai Q, Mazar AP, Kuo A, Parry GC, Shaw DE, Callahan J et al (2006) Structure of human urokinase plasminogen activator in complex with its receptor. Science 311(5761):656\u2013659","journal-title":"Science"},{"issue":"1","key":"5167_CR27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00045391-200301000-00003","volume":"10","author":"S Khosla","year":"2003","unstructured":"Khosla S, Jain P, Manda R, Razminia M, Guerrero M, Trivedi A et al (2003) Acute and long-term results after intra-arterial thrombolysis of occluded lower extremity bypass grafts using recombinant tissue plasminogen activator for acute limb-threatening ischemia. Am J Ther 10(1):3\u20136","journal-title":"Am J Ther"},{"issue":"27","key":"5167_CR28","doi-asserted-by":"crossref","first-page":"24421","DOI":"10.1074\/jbc.M301825200","volume":"278","author":"LV Mundada","year":"2003","unstructured":"Mundada LV, Prorok M, DeFord ME, Figuera M, Castellino FJ, Fay WP (2003) Structure-function analysis of the streptokinase amino terminus (residues 1\u201359). J Biol Chem 278(27):24421\u201324427","journal-title":"J Biol Chem"},{"issue":"5","key":"5167_CR29","doi-asserted-by":"crossref","first-page":"22B","DOI":"10.1016\/S0735-1097(87)80424-2","volume":"10","author":"JL Anderson","year":"1987","unstructured":"Anderson JL (1987) Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent. J Am Coll Cardiol 10(5):22B\u201327B","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5167_CR30","first-page":"2129","volume":"6","author":"THT Nguyen","year":"2012","unstructured":"Nguyen THT, Quyen DT (2012) High-level expression, purification and properties of a fully active even glycosylated staphylokinase variant SakfC from Staphylococcus aureus QT08 in Pichia pastoris. Afr J Microbiol Res 6(9):2129\u20132136","journal-title":"Afr J Microbiol Res"},{"issue":"5","key":"5167_CR31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ihj.2013.08.032","volume":"65","author":"J Dalal","year":"2013","unstructured":"Dalal J, Sahoo PK, Singh RK, Dhall A, Kapoor R, Krishnamurthy A et al (2013) Role of thrombolysis in reperfusion therapy for management of AMI: Indian scenario. Indian Heart J 65(5):566","journal-title":"Indian Heart J"},{"key":"5167_CR32","first-page":"269","volume":"3","author":"HD White","year":"1998","unstructured":"White HD (1998) Thrombolytic therapy and equivalence trials. Q J Cardiol 3:269\u2013271","journal-title":"Q J Cardiol"},{"issue":"5","key":"5167_CR33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1055\/s-0038-1648951","volume":"72","author":"R Koster","year":"1994","unstructured":"Koster R, Cohen A, Hopkins G, Beier H, G\u00fcnzler W, van der Wouw P (1994) Pharmacokinetics and pharmacodynamics of saruplase, an unglycosylated single-chain urokinase-type plasminogen activator, in patients with acute myocardial infarction. Thromb Haemost 72(5):740\u2013744","journal-title":"Thromb Haemost"},{"issue":"6","key":"5167_CR34","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S1051-0443(95)71241-6","volume":"6","author":"D Cutler","year":"1995","unstructured":"Cutler D, Bode C, Runge MS (1995) The promise of new genetically engineered plasminogen activators. J Vasc Interv Radiol 6(6):3S\u20137S","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"5167_CR35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/clc.4960220303","volume":"22","author":"AM Ross","year":"1999","unstructured":"Ross AM (1999) New plasminogen activators: a clinical review. Clin Cardiol 22(3):165\u2013171","journal-title":"Clin Cardiol"},{"issue":"9","key":"5167_CR36","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.5012\/bkcs.2010.31.9.2607","volume":"31","author":"H-J Lee","year":"2010","unstructured":"Lee H-J, Im H-N (2010) Soluble expression and purification of human tissue-type plasminogen activator protease domain. Bull Korean Chem Soc 31(9):2607\u20132612","journal-title":"Bull Korean Chem Soc"},{"issue":"13","key":"5167_CR37","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1016\/S0021-9258(19)69095-2","volume":"256","author":"DC Rijken","year":"1981","unstructured":"Rijken DC, Collen D (1981) Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 256(13):7035\u20137041","journal-title":"J Biol Chem"},{"issue":"20","key":"5167_CR38","doi-asserted-by":"crossref","first-page":"12994","DOI":"10.1016\/S0021-9258(18)98794-6","volume":"266","author":"VV Novokhatny","year":"1991","unstructured":"Novokhatny VV, Ingham KC, Medved LV (1991) Domain structure and domain-domain interactions of recombinant tissue plasminogen activator. J Biol Chem 266(20):12994\u201313002","journal-title":"J Biol Chem"},{"key":"5167_CR39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0049-3848(90)90379-Q","volume":"57","author":"D Rijken","year":"1990","unstructured":"Rijken D, Otter M, Kuiper J, Van Berkel TJ (1990) Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells. Thromb Res 57:63\u201371","journal-title":"Thromb Res"},{"issue":"4","key":"5167_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/21655979.2016.1229718","volume":"8","author":"YP Adivitiya Khasa","year":"2017","unstructured":"Adivitiya Khasa YP (2017) The evolution of recombinant thrombolytics: Current status and future directions. Bioengineered 8(4):331\u2013358","journal-title":"Bioengineered"},{"issue":"7","key":"5167_CR41","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1182\/blood.V73.7.1842.1842","volume":"73","author":"GR Larsen","year":"1989","unstructured":"Larsen GR, Metzger M, Henson K, Blue Y, Horgan P (1989) Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat. Blood 73(7):1842\u20131850","journal-title":"Blood"},{"issue":"8","key":"5167_CR42","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.2042-7158.2012.01457.x","volume":"64","author":"M Flemmig","year":"2012","unstructured":"Flemmig M, Melzig MF (2012) Serine-proteases as plasminogen activators in terms of fibrinolysis. J Pharm Pharmacol 64(8):1025\u20131039","journal-title":"J Pharm Pharmacol"},{"issue":"11","key":"5167_CR43","first-page":"4629","volume":"41","author":"L Liotta","year":"1981","unstructured":"Liotta L, Goldfarb R, Brundage R, Siegal G, Terranova V, Garbisa S (1981) Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41(11):4629","journal-title":"Cancer Res"},{"issue":"6","key":"5167_CR44","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0735-1097(87)80457-6","volume":"9","author":"EJ Topol","year":"1987","unstructured":"Topol EJ, Morris DC, Smalling RW, Schumacher RR, Taylor CR, Nishikawa A et al (1987) A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction. J Am Coll Cardiol 9(6):1205\u20131213","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"5167_CR45","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/cncr.22983","volume":"110","author":"G Mudduluru","year":"2007","unstructured":"Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH et al (2007) Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110(8):1697\u20131707. https:\/\/doi.org\/10.1002\/cncr.22983","journal-title":"Cancer"},{"issue":"3","key":"5167_CR46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/eurheartj\/eht409","volume":"35","author":"P Widimsky","year":"2013","unstructured":"Widimsky P, Coram R, Abou-Chebl A (2013) Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences. Eur Heart J 35(3):147\u2013155","journal-title":"Eur Heart J"},{"issue":"8699","key":"5167_CR47","first-page":"1175","volume":"335","author":"R Wilcox","year":"1990","unstructured":"Wilcox R, Von der Lippe G, Olsson C, Jensen G, Skene A, Hampton J (1990) Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Lancet 335(8699):1175\u20131178","journal-title":"Lancet"},{"issue":"9834","key":"5167_CR48","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","volume":"379","author":"JM Wardlaw","year":"2012","unstructured":"Wardlaw JM, Murray V, Berge E, Del Zoppo G, Sandercock P, Lindley RL et al (2012) Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 379(9834):2364\u20132372","journal-title":"Lancet"},{"issue":"10","key":"5167_CR49","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S1474-4422(16)30139-9","volume":"15","author":"E Berge","year":"2016","unstructured":"Berge E, Cohen G, Roaldsen MB, Lundstr\u00f6m E, Isaksson E, Rudberg A-S et al (2016) Effects of alteplase on survival after ischaemic stroke (IST-3): 3\u00a0year follow-up of a randomised, controlled, open-label trial. Lancet Neurol 15(10):1028\u20131034","journal-title":"Lancet Neurol"},{"issue":"24","key":"5167_CR50","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa1515510","volume":"374","author":"CS Anderson","year":"2016","unstructured":"Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee T-H et al (2016) Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 374(24):2313\u20132323","journal-title":"N Engl J Med"},{"issue":"3","key":"5167_CR51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0167-4838(92)90095-U","volume":"1160","author":"J Mimuro","year":"1992","unstructured":"Mimuro J, Kaneko M, Murakami T, Matsuda M, Sakata Y (1992) Reversible interactions between plasminogen activators and plasminogen activator inhibitor-1. Biochim Biophysi Acta 1160(3):325\u2013334","journal-title":"Biochim Biophysi Acta"},{"key":"5167_CR52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-1-4614-8948-1_24","volume-title":"Anticoagulant drugs. Essentials of pharmacology anesthesia, pain medicine critical care","author":"S Biswas","year":"2015","unstructured":"Biswas S, Sasaki J, Braunfeld M (2015) Anticoagulant drugs. Essentials of pharmacology anesthesia, pain medicine critical care. Springer, New York, pp 397\u2013413"},{"key":"5167_CR53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0140-6736(92)91893-D","volume":"339","author":"K Swedberg","year":"1992","unstructured":"Swedberg K (1992) ISSIS-3 (Third International Study of Infarct Survival) Collaborative Gruop. ISIS-3 a randomized trial of streptokinase versus Tissue plasmino gen activator versus anistreplase and aspirin plus heparine vs aspirina lone among 41229 cases of suspected acute myocardial infarction. Lancet 339:753\u2013770","journal-title":"Lancet"},{"key":"5167_CR54","first-page":"320","volume-title":"Modern pharmacology","author":"CS Craig","year":"1994","unstructured":"Craig CS, Stitzel RE (1994) Modern pharmacology, 4th edn. Little, Brown and Company, New York, p 320","edition":"4"},{"issue":"1","key":"5167_CR55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0002-9343(00)00380-6","volume":"109","author":"M Verstraete","year":"2000","unstructured":"Verstraete M (2000) Third-generation thrombolytic drugs. Am J Med 109(1):52\u201358","journal-title":"Am J Med"},{"issue":"15","key":"5167_CR56","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2165\/00003088-200241150-00001","volume":"41","author":"P Tanswell","year":"2002","unstructured":"Tanswell P, Modi N, Combs D, Danays T (2002) Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin Pharmacokinet 41(15):1229\u20131245","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"5167_CR57","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2003.09.009","volume":"185","author":"PA Lapchak","year":"2004","unstructured":"Lapchak PA, Araujo DM, Zivin JA (2004) Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits. Exp Neurol 185(1):154\u2013159","journal-title":"Exp Neurol"},{"key":"5167_CR58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/VHRM.S3848","volume":"5","author":"G Melandri","year":"2009","unstructured":"Melandri G, Vagnarelli F, Calabrese D, Semprini F, Nanni S, Branzi A (2009) Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction. Vasc Health Risk Manag 5:249","journal-title":"Vasc Health Risk Manag"},{"issue":"9180","key":"5167_CR59","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","volume":"354","author":"F Van de Werf","year":"1999","unstructured":"Van de Werf F (1999) Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 354(9180):716\u2013722","journal-title":"Lancet"},{"issue":"2\u20133","key":"5167_CR60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1054\/fipr.2000.0070","volume":"14","author":"D Collen","year":"2000","unstructured":"Collen D, Lijnen H (2000) Recent developments in thrombolytic therapy. Fibrinol Proteol 14(2\u20133):66\u201372","journal-title":"Fibrinol Proteol"},{"issue":"4","key":"5167_CR61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1527-3466.2004.tb00149.x","volume":"22","author":"T Inoue","year":"2004","unstructured":"Inoue T, Nishiki R, Kageyama M, Node K (2004) Therapeutic potential of monteplase in acute myocardial infarction as a powerful thrombolytic agent for pretreatment of coronary intervention. Cardiovasc Drug Rev 22(4):320\u2013333","journal-title":"Cardiovasc Drug Rev"},{"key":"5167_CR62","unstructured":"Bode C, Smalling R, Sen S, Kalbfleisch J, Boehm E, Odenheimer D et al., (ed) (1993) Recombinant plasminogen-activator angiographic phase-ii international dose-finding study (rapid)-patency analysis and mortality end-points. Circulation AMER HEART ASSOC 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596"},{"issue":"1","key":"5167_CR63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40259-015-0116-7","volume":"29","author":"BA Baldo","year":"2015","unstructured":"Baldo BA (2015) Enzymes approved for human therapy: indications, mechanisms and adverse effects. BioDrugs. 29(1):31\u201355","journal-title":"BioDrugs."},{"issue":"1","key":"5167_CR64","doi-asserted-by":"crossref","first-page":"253S","DOI":"10.1378\/chest.119.1_suppl.253S","volume":"119","author":"EM Ohman","year":"2001","unstructured":"Ohman EM, Harrington RA, Cannon CP, Agnelli G, Cairns JA, Kennedy JW (2001) Intravenous thrombolysis in acute myocardial infarction. Chest 119(1):253S\u2013277S","journal-title":"Chest"},{"issue":"1","key":"5167_CR65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3949\/ccjm.71.1.20","volume":"71","author":"K Ellis","year":"2004","unstructured":"Ellis K, Brener S (2004) New fibrinolytic agents for MI: as effective as current agents, but easier to administer. Clevel Clin J Med 71(1):20\u201339","journal-title":"Clevel Clin J Med"},{"key":"5167_CR66","first-page":"109","volume":"23","author":"GS Wander","year":"2013","unstructured":"Wander GS, Chhabra ST (2013) Critical analysis of various drugs used for thrombolytic therapy in acute myocardial infarction. Med Updat 23:109\u2013116","journal-title":"Med Updat"},{"issue":"7","key":"5167_CR67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/138161206776056065","volume":"12","author":"S Ueshima","year":"2006","unstructured":"Ueshima S, Matsuo O (2006) Development of new fibrinolytic agents. Curr Pharm Des 12(7):849\u2013857","journal-title":"Curr Pharm Des"},{"issue":"3","key":"5167_CR68","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MAJ.0000000000000392","volume":"349","author":"FJ Bosques-Padilla","year":"2015","unstructured":"Bosques-Padilla FJ, V\u00e1zquez-Elizondo G, Gonz\u00e1lez-Santiago O, Del Follo-Mart\u00ednez L, Gonz\u00e1lez OP, Gonz\u00e1lez-Gonz\u00e1lez JA et al (2015) Hypertriglyceridemia-induced pancreatitis and risk of persistent systemic inflammatory response syndrome. Am J Med Sci 349(3):206\u2013211","journal-title":"Am J Med Sci"},{"issue":"6","key":"5167_CR69","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0049-3848(00)00414-X","volume":"101","author":"K Oikawa","year":"2001","unstructured":"Oikawa K, Kamimura H, Watanabe T, Miyamoto I, Higuchi S (2001) Pharmacokinetic properties of a novel tissue-type plasminogen activator pamiteplase after single intravenous administration to rats, dogs, and monkeys. Thromb Res 101(6):493\u2013500","journal-title":"Thromb Res"},{"key":"5167_CR70","volume-title":"Fibrinolytics and antifibrinolytics","author":"F Bachmann","year":"2012","unstructured":"Bachmann F (2012) Fibrinolytics and antifibrinolytics. Springer Science & Business Media, New York"},{"issue":"04","key":"5167_CR71","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1160\/TH04-11-0724","volume":"93","author":"D Collen","year":"2005","unstructured":"Collen D, Lijnen RH (2005) Thrombolytic agents. Thromb Haemost 93(04):627\u2013630","journal-title":"Thromb Haemost"},{"issue":"2","key":"5167_CR72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2131\/jts.22.2_117","volume":"22","author":"A Ishikawa","year":"1997","unstructured":"Ishikawa A, Ohata T, Imamura K, Iwasaki M, Sakai T, Matsuzawa T et al (1997) Single and repeated intravenous toxicity studies of pamiteplase (genetical recombination) in rats and monkeys. J Toxicol Sci 22(2):117\u2013133","journal-title":"J Toxicol Sci"},{"issue":"1","key":"5167_CR73","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2141.1997.9962641.x","volume":"97","author":"M Ieko","year":"1997","unstructured":"Ieko M, Sawada K, Yasukouchi T, Sakurama S, Tohma Y, Shiroshita K et al (1997) Protection by \u03b12-macroglobulin of tissue plasminogen activator against inhibition by plasminogen activator inhibitor-1. Br J Haematol 97(1):214\u2013218","journal-title":"Br J Haematol"},{"issue":"17","key":"5167_CR74","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.csbj.2019.06.023","volume":"2","author":"J Mican","year":"2019","unstructured":"Mican J, Toul M, Bednar D, Damborsky J (2019) Structural biology and protein engineering of thrombolytics. Comput Struct Biotechnol J 2(17):917\u2013938","journal-title":"Comput Struct Biotechnol J"},{"issue":"10","key":"5167_CR75","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/oxfordjournals.eurheartj.a014716","volume":"17","author":"A Malcolm","year":"1996","unstructured":"Malcolm A, Keltai M, Walsh M (1996) ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction. Eur Heart J 17(10):1522\u20131531","journal-title":"Eur Heart J"},{"issue":"01","key":"5167_CR76","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1160\/TH03-07-0435","volume":"91","author":"DC Rijken","year":"2004","unstructured":"Rijken DC, Barrett-Bergshoeff MM, Jie A, Criscuoli M, Sakharov DV (2004) Clot penetration and fibrin binding of amediplase, a chimeric plasminogen activator (K2tu-PA). Thromb Haemost 91(01):52\u201360","journal-title":"Thromb Haemost"},{"issue":"09","key":"5167_CR77","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1160\/TH06-04-0197","volume":"96","author":"AH Guimar\u00e3es","year":"2006","unstructured":"Guimar\u00e3es AH, Barrett-Bergshoeff MM, Criscuoli M, Evangelista S, Rijken DC (2006) Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models. Thromb Haemost 96(09):325\u2013330","journal-title":"Thromb Haemost"},{"key":"5167_CR78","first-page":"S9","volume":"73","author":"D Gulba","year":"1996","unstructured":"Gulba D, Bode C, Runge M, Huber K (1996) Thrombolytic agents\u2013an overview. Ann Hematol 73:S9\u2013S27","journal-title":"Ann Hematol"},{"key":"5167_CR79","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0268-9499(97)80033-1","volume":"11","author":"C Bode","year":"1997","unstructured":"Bode C, Peter K, Nordt T, Kohler B, Moser M, Ruef J et al (1997) New developments in thrombolytic therapy. Fibrinol Proteol 11:109\u2013114. https:\/\/doi.org\/10.1016\/S0268-9499(97)80033-1","journal-title":"Fibrinol Proteol"},{"issue":"5","key":"5167_CR80","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/01.CIR.91.5.1540","volume":"91","author":"M Montoney","year":"1995","unstructured":"Montoney M, Gardell SJ, Marder VJ (1995) Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model. Circulation 91(5):1540\u20131544","journal-title":"Circulation"},{"issue":"17","key":"5167_CR81","doi-asserted-by":"crossref","first-page":"10246","DOI":"10.1074\/jbc.270.17.10246","volume":"270","author":"Y Zhang","year":"1995","unstructured":"Zhang Y, Wisner A, Xiong Y, Bon C (1995) A novel plasminogen activator from snake venom purification, characterization, and molecular cloning. J Biol Chem 270(17):10246\u201310255","journal-title":"J Biol Chem"},{"issue":"12","key":"5167_CR82","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0041-0101(98)00090-7","volume":"36","author":"D Park","year":"1998","unstructured":"Park D, Kim H, Chung K, Kim DS, Yun Y (1998) Expression and characterization of a novel plasminogen activator from Agkistrodon halys venom. Toxicon 36(12):1807\u20131819","journal-title":"Toxicon"},{"issue":"12","key":"5167_CR83","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.bbagen.2006.08.023","volume":"1760","author":"EF Sanchez","year":"2006","unstructured":"Sanchez EF, Felicori LF, Chavez-Olortegui C, Magalhaes HB, Hermogenes AL, Diniz MV et al (2006) Biochemical characterization and molecular cloning of a plasminogen activator proteinase (LV-PA) from bushmaster snake venom. Biochim Biophys Acta (BBA) 1760(12):1762\u20131771","journal-title":"Biochim Biophys Acta (BBA)"},{"issue":"2","key":"5167_CR84","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0167-4838(01)00161-3","volume":"1546","author":"J Jiao","year":"2001","unstructured":"Jiao J, Yu M, Ru B (2001) Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding. Biochim Biophys Acta (BBA) 1546(2):399\u2013405","journal-title":"Biochim Biophys Acta (BBA)"},{"key":"5167_CR85","first-page":"108159","volume":"2010","author":"F Davami","year":"2010","unstructured":"Davami F, Sardari S, Majidzadeh AK, Hemayatkar M, Barkhrdari F, Omidi M et al (2010) Expression of a novel chimeric truncated t-PA in CHO cells based on in silico experiments. BioMed Res Int 2010:108159","journal-title":"BioMed Res Int"},{"issue":"4","key":"5167_CR86","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymgme.2004.05.008","volume":"82","author":"L Zhang","year":"2004","unstructured":"Zhang L, Wang J, Yu M, Ru B (2004) Functional properties of a recombinant chimeric plasminogen activator with platelet-targeted fibrinolytic and anticoagulant potential. Mol Genet Metab 82(4):304\u2013311","journal-title":"Mol Genet Metab"},{"issue":"1","key":"5167_CR87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1042\/bj0760056","volume":"76","author":"FM Davidson","year":"1960","unstructured":"Davidson FM (1960) The activation of plasminogen by staphylokinase: comparison with streptokinase. Biochem J 76(1):56","journal-title":"Biochem J"},{"issue":"1","key":"5167_CR88","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj0880011","volume":"88","author":"KL Glanville","year":"1963","unstructured":"Glanville KL (1963) A simple method of purifying staphylokinase. Biochem J 88(1):11","journal-title":"Biochem J"},{"issue":"2","key":"5167_CR89","first-page":"375","volume":"29","author":"B Sweet","year":"1965","unstructured":"Sweet B, McNicol G, Douglas A (1965) In vitro studies of staphylokinase. Clin Sci 29(2):375","journal-title":"Clin Sci"},{"issue":"5","key":"5167_CR90","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1152\/ajplegacy.1964.207.5.1044","volume":"207","author":"JH Lewis","year":"1964","unstructured":"Lewis JH, Kerber C, Wilson JH (1964) Effects of fibrinolytic agents and heparin on intravascular clot lysis. Am J Physiol 207(5):1044\u20131048","journal-title":"Am J Physiol"},{"issue":"5","key":"5167_CR91","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1152\/ajplegacy.1964.207.5.1049","volume":"207","author":"JH Lewis","year":"1964","unstructured":"Lewis JH, Shirakawa M (1964) Effects of fibrinolytic agents and heparin on blood coagulation in dogs. Am J Physiol 207(5):1049\u20131052","journal-title":"Am J Physiol"},{"key":"5167_CR92","unstructured":"Kanae K (ed) (1986) Fibrinolysis by staphylokinase in vivo. Biol Abstr"},{"key":"5167_CR93","first-page":"387","volume-title":"Streptokinase and staphylokinase. Methods in enzymology","author":"KW Jackson","year":"1981","unstructured":"Jackson KW, Esmon N, Tang J (1981) Streptokinase and staphylokinase. Methods in enzymology. Elsevier, Amsterdam, pp 387\u2013394"},{"key":"5167_CR94","unstructured":"Kondo I, Itoh S, Takagi T (1981) Purification of staphylokinase by affinity chromatography with human plasminogen. Staphylococci Staphylococcal Infect"},{"issue":"4123","key":"5167_CR95","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/162732a0","volume":"162","author":"EB Gerheim","year":"1948","unstructured":"Gerheim EB (1948) Staphlococcal coagulation and fibrinolysis. Nature 162(4123):732","journal-title":"Nature"},{"issue":"4093","key":"5167_CR96","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/161559b0","volume":"161","author":"CH Lack","year":"1948","unstructured":"Lack CH (1948) Staphylokinase; an activator of plasma protease. Nature 161(4093):559","journal-title":"Nature"},{"issue":"3","key":"5167_CR97","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1182\/blood.V84.3.680.680","volume":"84","author":"D Collen","year":"1994","unstructured":"Collen D, Lijnen H (1994) Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential? Blood 84(3):680\u2013686","journal-title":"Blood"},{"issue":"11","key":"5167_CR98","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1016\/S0021-9258(18)53094-5","volume":"268","author":"D Collen","year":"1993","unstructured":"Collen D, Schlott B, Engelborghs Y, Van Hoef B, Hartmann M, Lijnen H et al (1993) On the mechanism of the activation of human plasminogen by recombinant staphylokinase. J Biol Chem 268(11):8284\u20138289","journal-title":"J Biol Chem"},{"issue":"2","key":"5167_CR99","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0006-291X(89)92385-1","volume":"162","author":"M Sakai","year":"1989","unstructured":"Sakai M, Watanuki M, Matsuo O (1989) Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of \u03b12-plasmin inhibitor. Biochem Biophys Res Commun 162(2):830\u2013837","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"5167_CR100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0167-4838(92)90142-Z","volume":"1118","author":"HR Lijnen","year":"1992","unstructured":"Lijnen HR, Van Hoef B, Matsuo O, Collen D (1992) On the molecular interactions between plasminogen-staphylokinase, \u03b12-antiplasmin-formula > and fibrin. Biochim Biophys Acta (BBA) 1118(2):144\u2013148","journal-title":"Biochim Biophys Acta (BBA)"},{"issue":"2","key":"5167_CR101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0049-3848(94)90188-0","volume":"76","author":"K Okada","year":"1994","unstructured":"Okada K, Yuasa H, Hagiya Y, Fukao H, Ueshima S, Matsuo O (1994) Kinetic analysis of plasminogen activation by staphylokinase\/plasminogen complex in the presence of fibrin. Thromb Res 76(2):181\u2013191","journal-title":"Thromb Res"},{"issue":"18","key":"5167_CR102","doi-asserted-by":"crossref","first-page":"11826","DOI":"10.1016\/S0021-9258(18)99031-9","volume":"266","author":"H Lijnen","year":"1991","unstructured":"Lijnen H, Van Hoef B, De Cock F, Okada K, Ueshima S, Matsuo O et al (1991) On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem 266(18):11826\u201311832","journal-title":"J Biol Chem"},{"issue":"3","key":"5167_CR103","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-8652(199611)53:3<151::AID-AJH1>3.0.CO;2-Y","volume":"53","author":"K Okada","year":"1996","unstructured":"Okada K, Ueshima S, Takaishi T, Yuasa H, Fukao H, Matsuo O (1996) Effects of fibrin and \u03b12-antiplasmin on plasminogen activation by staphylokinase. Am J Hematol 53(3):151\u2013157","journal-title":"Am J Hematol"},{"key":"5167_CR104","unstructured":"http:\/\/www.thrombogenics.com"},{"issue":"4","key":"5167_CR105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.biocel.2005.07.005","volume":"38","author":"MI Bokarewa","year":"2006","unstructured":"Bokarewa MI, Jin T, Tarkowski A (2006) Staphylococcus aureus: staphylokinase. Int J Biochem Cell Biol 38(4):504\u2013509","journal-title":"Int J Biochem Cell Biol"},{"issue":"26","key":"5167_CR106","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1021\/bi00269a001","volume":"21","author":"KW Jackson","year":"1982","unstructured":"Jackson KW, Tang J (1982) Complete amino acid sequence of streptokinase and its homology with serine proteases. Biochemistry 21(26):6620\u20136625","journal-title":"Biochemistry"},{"issue":"2\u20133","key":"5167_CR107","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0167-4838(93)90220-L","volume":"1161","author":"G Damaschun","year":"1993","unstructured":"Damaschun G, Damaschun H, Gast K, Misselwitz R, Zirwer D, G\u00fchrs K-H et al (1993) Physical and conformational properties of staphylokinase in solution. Biochim Biophys Acta (BBA) 1161(2\u20133):244\u2013248","journal-title":"Biochim Biophys Acta (BBA)"},{"issue":"7","key":"5167_CR108","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/656140","volume":"202","author":"J Kwieci\u0144ski","year":"2010","unstructured":"Kwieci\u0144ski J, Josefsson E, Mitchell J, Higgins J, Magnusson M, Foster T et al (2010) Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. J Infect Dis 202(7):1041\u20131049","journal-title":"J Infect Dis"},{"issue":"3","key":"5167_CR109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02932545","volume":"6","author":"J-H Kim","year":"2001","unstructured":"Kim J-H, Wong S-L, Kim B-G (2001) Optimization of staphylokinase production inBacillus subtilis using inducible and constitutive promoters. Biotechnol Bioprocess Eng 6(3):167","journal-title":"Biotechnol Bioprocess Eng"},{"issue":"2","key":"5167_CR110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0167-4838(94)90013-2","volume":"1204","author":"B Schlott","year":"1994","unstructured":"Schlott B, Hartmann M, G\u00fchrs K-H, Birch-Hirschfeld E, Gase A, Vettermann S et al (1994) Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26. Biochim Biophys Acta (BBA) 1204(2):235\u2013242","journal-title":"Biochim Biophys Acta (BBA)"},{"issue":"4","key":"5167_CR111","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1182\/blood.V96.4.1425","volume":"96","author":"Y Laroche","year":"2000","unstructured":"Laroche Y, Heymans S, Capaert S, De Cock F, Demarsin E, Collen D (2000) Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes. Blood 96(4):1425\u20131432","journal-title":"Blood"},{"issue":"10","key":"5167_CR112","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1111\/j.1538-7836.2005.01480.x","volume":"3","author":"J Szemraj","year":"2005","unstructured":"Szemraj J, Walkowiak B, Kawecka I, Janiszewska G, Janiszewska G, Buczko W, Bartkowiak J et al (2005) IN FOCUS: a new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity\u2013a staphylokinase variant. I. In vitro study. J Thromb Haemost 3(10):2156\u20132165","journal-title":"J Thromb Haemost"},{"issue":"10","key":"5167_CR113","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0169-409X(03)00113-3","volume":"55","author":"RW Moreadith","year":"2003","unstructured":"Moreadith RW, Collen D (2003) Clinical development of PEGylated recombinant staphylokinase (PEG\u2013Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction. Adv Drug Deliv Rev 55(10):1337\u20131345","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"5167_CR114","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/019262301316905237","volume":"29","author":"L Moons","year":"2001","unstructured":"Moons L, Vanlinthout I, Roelants I, Moreadith R, Collen D, Rapold HJ (2001) toxicology studies with recombinant staphylokinase and with SY 161-P5, a polyethylene glycol-derivatized Cysteine-Substitution Mutant. Toxicol Pathol 29(3):285\u2013291","journal-title":"Toxicol Pathol"},{"issue":"9","key":"5167_CR115","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/abbs\/gmu068","volume":"46","author":"J Liu","year":"2014","unstructured":"Liu J, Wang Z, He J, Wang G, Zhang R, Zhao B (2014) Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase. Acta Biochim Biophys Sin 46(9):782\u2013791","journal-title":"Acta Biochim Biophys Sin"},{"key":"5167_CR116","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijbiomac.2018.10.134","volume":"121","author":"ST Mannully","year":"2019","unstructured":"Mannully ST, Shanthi C, Pulicherla KK (2019) Lipid modification of staphylokinase and its implications on stability and activity. Int J Biol Macromol 121:1037\u20131045","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"5167_CR117","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0735-1097(90)90364-U","volume":"16","author":"T Yasuda","year":"1990","unstructured":"Yasuda T, Gold HK, Yaoita H, Leinbach RC, Guerrero JL, Jang I-K et al (1990) Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb\/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation. J Am Coll Cardiol 16(3):714\u2013722","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"5167_CR118","doi-asserted-by":"crossref","first-page":"11766","DOI":"10.1016\/S0021-9258(19)38464-9","volume":"265","author":"B Savage","year":"1990","unstructured":"Savage B, Marzec U, Chao B, Harker L, Maraganore J, Ruggeri ZM (1990) Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site (s) on platelet glycoprotein IIb. IIIa complex inhibits receptor function. J Biol Chem 265(20):11766\u201311772","journal-title":"J Biol Chem"},{"issue":"6","key":"5167_CR119","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/01.CIR.80.6.1766","volume":"80","author":"BS Coller","year":"1989","unstructured":"Coller BS, Folts JD, Smith SR, LE Scudder, Jordan R (1989) Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb\/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb\/IIIa receptors. Circulation 80(6):1766\u20131774","journal-title":"Circulation"},{"issue":"4966","key":"5167_CR120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1126\/science.2374926","volume":"249","author":"TJ Rydel","year":"1990","unstructured":"Rydel TJ, Ravichandran K, Tulinsky A, Bode W, Huber R, Roitsch C et al (1990) The structure of a complex of recombinant hirudin and human alpha-thrombin. Science 249(4966):277\u2013280","journal-title":"Science"},{"issue":"24","key":"5167_CR121","doi-asserted-by":"crossref","first-page":"14290","DOI":"10.1073\/pnas.95.24.14290","volume":"95","author":"M Cappello","year":"1998","unstructured":"Cappello M, Li S, Chen X, Li C-B, Harrison L, Narashimhan S et al (1998) Tsetse thrombin inhibitor: bloodmeal-induced expression of an anticoagulant in salivary glands and gut tissue of Glossina morsitans morsitans. Proc Natl Acad Sci 95(24):14290\u201314295","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"5167_CR122","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s10529-009-0094-2","volume":"31","author":"M Wang","year":"2009","unstructured":"Wang M, Wang Y, Wang J, Zou M, Liu S, Xu T et al (2009) Construction and characterization of a novel staphylokinase variant with thrombin-inhibitory activity. Biotechnol Lett 31(12):1923\u20131927","journal-title":"Biotechnol Lett"},{"issue":"4","key":"5167_CR123","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/0022-2836(91)90939-4","volume":"221","author":"E Skrzypczak-Jankun","year":"1991","unstructured":"Skrzypczak-Jankun E, Carperos VE, Ravichandran K, Tulinsky A, Westbrook M, Maraganore JM (1991) Structure of the hirugen and hirulog 1 complexes of \u03b1-thrombin. J Mol Biol 221(4):1379\u20131393","journal-title":"J Mol Biol"},{"issue":"5","key":"5167_CR124","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0049-3848(97)00277-6","volume":"88","author":"WB Van Zyl","year":"1997","unstructured":"Van Zyl WB, Pretorius GH, Hartmann M, Kotz\u00e9 HF (1997) Production of a recombinant antithrombotic and fibrinolytic protein, PLATSAK in Escherichia coli. Thromb Res 88(5):419\u2013426","journal-title":"Thromb Res"},{"issue":"2","key":"5167_CR125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/mol.62.2.203","volume":"62","author":"C Icke","year":"2002","unstructured":"Icke C, Schlott B, Ohlenschl\u00e4ger O, Hartmann M, G\u00fchrs K-H, Glusa E (2002) Fusion proteins with anticoagulant and fibrinolytic properties: functional studies and structural considerations. Mol Pharmacol 62(2):203\u2013209","journal-title":"Mol Pharmacol"},{"issue":"4","key":"5167_CR126","first-page":"107","volume":"5","author":"K Seetha Ram","year":"2013","unstructured":"Seetha Ram K, Peravali JB, Sudheer Y, Anmol K, Rao KRSSS, Pulicherla KK (2013) Large scale production of soluble recombinant staphylokinase variant from cold shock expression system using IPTG inducible E. coli BL21(DE3). Int J Bio-Sci Bio-Technol 5(4):107\u2013116","journal-title":"Int J Bio-Sci Bio-Technol"},{"issue":"24","key":"5167_CR127","doi-asserted-by":"publisher","first-page":"14290","DOI":"10.1073\/pnas.95.24.14290","volume":"95","author":"M Cappello","year":"1998","unstructured":"Cappello M, Li S, Chen X, Li CB, Harrison L, Narashimhan S et al (1998) Tsetse thrombin inhibitor: bloodmeal-induced expression of an anticoagulant in salivary glands and gut tissue of Glossina morsitans morsitans. Proc Natl Acad Sci USA 95(24):14290\u201314295. https:\/\/doi.org\/10.1073\/pnas.95.24.14290","journal-title":"Proc Natl Acad Sci USA"},{"issue":"29","key":"5167_CR128","doi-asserted-by":"crossref","first-page":"17746","DOI":"10.1016\/S0021-9258(18)38226-7","volume":"265","author":"M Neeper","year":"1990","unstructured":"Neeper M, Waxman L, Smith D, Schulman C, Sardana M, Ellis R et al (1990) Characterization of recombinant tick anticoagulant peptide. A highly selective inhibitor of blood coagulation factor Xa. J Biol Chem 265(29):17746\u201317752","journal-title":"J Biol Chem"},{"issue":"2","key":"5167_CR129","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.CIR.82.2.578","volume":"82","author":"A Gruber","year":"1990","unstructured":"Gruber A, Hanson SR, Kelly AB, Yan BS, Bang N, Griffin JH et al (1990) Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation 82(2):578\u2013585","journal-title":"Circulation"},{"key":"5167_CR130","first-page":"107","volume":"5","author":"SR Kotra","year":"2013","unstructured":"Kotra SR, Peravali J, Yanamadala S, Kumar A, Samba Siva Rao K, Pulicherla K (2013) Large scale production of soluble recombinant staphylokinase variant from cold shock expression system using IPTG inducible E. coli BL21 (DE3). Int J Bio-Sci Bio-Technol 5:107\u2013116","journal-title":"Int J Bio-Sci Bio-Technol"},{"issue":"22","key":"5167_CR131","first-page":"5995","volume":"11","author":"THT Nguyen","year":"2012","unstructured":"Nguyen THT, Quyen DT (2012) Cloning, high-level expression, purification and characterization of a staphylokinase variant, Sak\u00f8C, from Staphylococcus aureus QT08 in Escherichia coli BL21. Afr J Biotech 11(22):5995\u20136003","journal-title":"Afr J Biotech"},{"issue":"4","key":"5167_CR132","first-page":"266","volume":"6","author":"YGP Reddy","year":"2014","unstructured":"Reddy YGP, Prakash R, Anandakumar S (2014) Isolation, cloning and expression of recombinant staphylokinase gene against thrombosis. J Pharm Pharm Sci. 6(4):266\u2013270","journal-title":"J Pharm Pharm Sci."},{"issue":"12","key":"5167_CR133","first-page":"10","volume":"4","author":"H Jasim","year":"2015","unstructured":"Jasim H, Dellol R, Hamzah A (2015) Optimum conditions of staphylokinase production cloned in E. coli Jm109 (DE3). Int J Curr Microbiol Appl Sci 4(12):10\u201319","journal-title":"Int J Curr Microbiol Appl Sci"},{"issue":"3","key":"5167_CR134","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0176-6724(88)80174-3","volume":"269","author":"D Gerlach","year":"1988","unstructured":"Gerlach D, Kraft R, Behnke D (1988) Purification and characterization of the bacterial plasminogen activator staphylokinase secreted by a recombinant Bacillus subtilis. Zentralblatt f\u00fcr Bakteriologie, Mikrobiologie und Hygiene Series A 269(3):314\u2013322","journal-title":"Zentralblatt f\u00fcr Bakteriologie, Mikrobiologie und Hygiene Series A"},{"issue":"1","key":"5167_CR135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1097-0290(19990105)62:1<87::AID-BIT10>3.0.CO;2-I","volume":"62","author":"R Ye","year":"1999","unstructured":"Ye R, Kim JH, Kim BG, Szarka S, Sihota E, Wong SL (1999) High-level secretory production of intact, biologically active staphylokinase from Bacillus subtilis. Biotechnol Bioeng 62(1):87\u201396","journal-title":"Biotechnol Bioeng"},{"key":"5167_CR136","first-page":"1008","volume":"3","author":"K Pulicherla","year":"2012","unstructured":"Pulicherla K, Seetharam K, Kumar A, Rekha V, Rao K (2012) Cloning and high level expression of recombinant heterologous fusion protein SAK RGD in methanol inducible Pichia pastoris GS115. Int J Res Pharm Biomed Sci 3:1008\u20131013","journal-title":"Int J Res Pharm Biomed Sci"},{"issue":"6","key":"5167_CR137","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10529-009-9938-z","volume":"31","author":"A Apte-Deshpnade","year":"2009","unstructured":"Apte-Deshpnade A, Mandal G, Soorapaneni S, Prasad B, Kumar J, Padmanabhan S (2009) High-level expression of non-glycosylated and active staphylokinase from Pichia pastoris. Biotechnol Lett 31(6):811\u2013817","journal-title":"Biotechnol Lett"},{"issue":"6","key":"5167_CR138","first-page":"428","volume":"20","author":"Y Cheng","year":"1998","unstructured":"Cheng Y, Li Y, Liu B, Guo L (1998) Cloning and secretory expression of staphylokinase in Streptomyces lividans. Zhongguo yi xue ke xue yuan xue bao Acta Academiae Medicinae Sinicae. 20(6):428\u2013432","journal-title":"Zhongguo yi xue ke xue yuan xue bao Acta Academiae Medicinae Sinicae."},{"issue":"1","key":"5167_CR139","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1472-6750-12-96","volume":"12","author":"M Moussa","year":"2012","unstructured":"Moussa M, Ibrahim M, El Ghazaly M, Rohde J, Gnoth S, Anton A et al (2012) Expression of recombinant staphylokinase in the methylotrophic yeast Hansenula polymorpha. BMC Biotechnol 12(1):96","journal-title":"BMC Biotechnol"},{"issue":"2","key":"5167_CR140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/yea.320050206","volume":"5","author":"LS Grinna","year":"1989","unstructured":"Grinna LS, Tschopp JF (1989) Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast. Pichia pastoris. Yeast. 5(2):107\u2013115","journal-title":"Pichia pastoris. Yeast."},{"issue":"7","key":"5167_CR141","doi-asserted-by":"crossref","first-page":"e0129914","DOI":"10.1371\/journal.pone.0129914","volume":"10","author":"H Kim","year":"2015","unstructured":"Kim H, Thak EJ, Lee D-J, Agaphonov MO, Kang HA (2015) Hansenula polymorpha Pmt4p plays critical roles in O-mannosylation of surface membrane proteins and participates in heteromeric complex formation. PLoS ONE 10(7):e0129914","journal-title":"PLoS ONE"},{"issue":"8","key":"5167_CR142","first-page":"905","volume":"11","author":"JM Cregg","year":"1993","unstructured":"Cregg JM, Vedvick TS, Raschke WC (1993) Recent advances in the expression of foreign genes in Pichia pastoris. Bio\/Technology 11(8):905","journal-title":"Bio\/Technology"},{"issue":"12","key":"5167_CR143","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1074\/jbc.274.12.7769","volume":"274","author":"RG Miele","year":"1999","unstructured":"Miele RG, Prorok M, Costa VA, Castellino FJ (1999) Glycosylation of asparagine-28 of recombinant staphylokinase with high-mannose-type oligosaccharides results in a protein with highly attenuated plasminogen activator activity. J Biol Chem 274(12):7769\u20137776","journal-title":"J Biol Chem"},{"issue":"9","key":"5167_CR144","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1074\/jbc.272.9.6067","volume":"272","author":"B Schlott","year":"1997","unstructured":"Schlott B, Guhrs KH, Hartmann M, Rocker A, Collen D (1997) Staphylokinase requires NH2-terminal proteolysis for plasminogen activation. J Biol Chem 272(9):6067\u20136072. https:\/\/doi.org\/10.1074\/jbc.272.9.6067","journal-title":"J Biol Chem"},{"issue":"1","key":"5167_CR145","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pep.2008.10.010","volume":"64","author":"N Mandi","year":"2009","unstructured":"Mandi N, Soorapaneni S, Rewanwar S, Kotwal P, Prasad B, Mandal G et al (2009) High yielding recombinant Staphylokinase in bacterial expression system\u2013cloning, expression, purification and activity studies. Protein Expr Purif 64(1):69\u201375. https:\/\/doi.org\/10.1016\/j.pep.2008.10.010","journal-title":"Protein Expr Purif"},{"issue":"2","key":"5167_CR146","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nbt0294-185","volume":"12","author":"B Schlott","year":"1994","unstructured":"Schlott B, Hartmann M, G\u00fchrs K-H, Birch-Hirschfeid E, Pohl H-D, Vanderschueren S et al (1994) High yield production and purification of recombinant staphylokinase for thrombolytic therapy. Bio\/Technology 12(2):185\u2013189. https:\/\/doi.org\/10.1038\/nbt0294-185","journal-title":"Bio\/Technology"},{"issue":"2","key":"5167_CR147","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/a:1005359920522","volume":"20","author":"SJ Lee","year":"1998","unstructured":"Lee SJ, Kim IC, Kim DM, Bae KH, Byun SM (1998) High level secretion of recombinant staphylokinase into periplasm of Escherichia coli. Biotechnol Lett 20(2):113\u2013116. https:\/\/doi.org\/10.1023\/a:1005359920522","journal-title":"Biotechnol Lett"},{"issue":"3","key":"5167_CR148","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S1046-5928(02)00040-2","volume":"25","author":"W Liu","year":"2002","unstructured":"Liu W, Zhu R-H, Li G-P, Wang D-C (2002) cDNA cloning, high-level expression, purification, and characterization of an avian Cu, Zn superoxide dismutase from Peking duck. Protein Expr Purif 25(3):379\u2013388. https:\/\/doi.org\/10.1016\/S1046-5928(02)00040-2","journal-title":"Protein Expr Purif"},{"issue":"2","key":"5167_CR149","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nbt0294-185","volume":"12","author":"B Schlott","year":"1994","unstructured":"Schlott B, Hartmann M, G\u00fchrs K-H, Birch-Hirschfeid E, Pohl H-D, Vanderschueren S et al (1994) High yield production and purification of recombinant staphylokinase for thrombolytic therapy. Nat Biotechnol 12(2):185","journal-title":"Nat Biotechnol"},{"issue":"9","key":"5167_CR150","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1074\/jbc.272.9.6067","volume":"272","author":"B Schlott","year":"1997","unstructured":"Schlott B, G\u00fchrs K-H, Hartmann M, R\u00f6cker A, Collen D (1997) Staphylokinase requires NH2-terminal proteolysis for plasminogen activation. J Biol Chem 272(9):6067\u20136072","journal-title":"J Biol Chem"},{"issue":"1","key":"5167_CR151","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pep.2008.10.010","volume":"64","author":"N Mandi","year":"2009","unstructured":"Mandi N, Soorapaneni S, Rewanwar S, Kotwal P, Prasad B, Mandal G et al (2009) High yielding recombinant Staphylokinase in bacterial expression system\u2014cloning, expression, purification and activity studies. Protein Expr Purif 64(1):69\u201375","journal-title":"Protein Expr Purif"},{"key":"5167_CR152","first-page":"35","volume":"30","author":"K Pulicherla","year":"2011","unstructured":"Pulicherla K, Gadupudi G, Rekha V, Seetharam K, Kumar A, Rao K (2011) Isolation, cloning and expression of mature staphylokinase from lysogenic Staphylococcus aureus collected from a local wound sample in a salt inducible E. coli expression host. Int J Adv Sci Technol 30:35\u201342","journal-title":"Int J Adv Sci Technol"},{"issue":"4","key":"5167_CR153","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/10826068.2016.1252924","volume":"47","author":"H Faraji","year":"2017","unstructured":"Faraji H, Ramezani M, Sadeghnia HR, Abnous K, Soltani F, Mashkani B (2017) High-level expression of a biologically active staphylokinase in Pichia pastoris. Prep Biochem Biotechnol 47(4):379\u2013387","journal-title":"Prep Biochem Biotechnol"},{"issue":"4","key":"5167_CR154","first-page":"27","volume":"4","author":"SR Kotra","year":"2012","unstructured":"Kotra SR, Kumar A, Rao KS, Pulicherla K (2012) Statistical optimization of media components for enhanced production of the recombinant staphylokinase variant from salt inducible E. Coli GJ1158. Int J Bio-Sci Bio-Technol 4(4):27\u201340","journal-title":"Int J Bio-Sci Bio-Technol"},{"issue":"29","key":"5167_CR155","doi-asserted-by":"crossref","first-page":"26677","DOI":"10.1074\/jbc.M303241200","volume":"278","author":"Q Lian","year":"2003","unstructured":"Lian Q, Szarka SJ, Ng KK, Wong S-L (2003) Engineering of a staphylokinase-based fibrinolytic agent with antithrombotic activity and targeting capability toward thrombin-rich fibrin and plasma clots. J Biol Chem 278(29):26677\u201326686","journal-title":"J Biol Chem"},{"issue":"1\u20133","key":"5167_CR156","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2007.03.010","volume":"566","author":"H Chen","year":"2007","unstructured":"Chen H, Mo W, Zhang Y, Su H, Ma J, Yao R et al (2007) Functional properties of a novel mutant of staphylokinase with platelet-targeted fibrinolysis and antiplatelet aggregation activities. Eur J Pharmacol 566(1\u20133):137\u2013144","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5167_CR157","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/AEM.65.2.506-513.1999","volume":"65","author":"S Szarka","year":"1999","unstructured":"Szarka S, Sihota E, Habibi H, Wong S-L (1999) Staphylokinase as a plasminogen activator component in recombinant fusion proteins. Appl Environ Microbiol 65(2):506\u2013513","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"5167_CR158","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S1734-1140(11)70636-3","volume":"63","author":"J Szemraj","year":"2011","unstructured":"Szemraj J, Zakrzeska A, Brown G, Stankiewicz A, Gromotowicz A, Gr\u0119dzi\u0144ski T et al (2011) New derivative of staphylokinase SAK-RGD-K2-Hirul exerts thrombolytic effects in the arterial thrombosis model in rats. Pharmacol Rep 63(5):1169\u20131179","journal-title":"Pharmacol Rep"},{"issue":"2","key":"5167_CR159","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11239-008-0251-9","volume":"28","author":"W Mo","year":"2009","unstructured":"Mo W, Zhang Y-L, Chen H-S, Wang L-S, Song H-Y (2009) A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition. J Thromb Thromb 28(2):230\u2013237","journal-title":"J Thromb Thromb"},{"issue":"10","key":"5167_CR160","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1139\/cjpp-2012-0467","volume":"91","author":"A Kumar","year":"2013","unstructured":"Kumar A, Kumar A, Pulicherla KK, Mayuren C, Kotra S, Rao KRS (2013) Evaluation of a multifunctional staphylokinase variant with thrombin inhibition and antiplatelet aggregation activities produced from salt-inducible E. coli GJ1158. Can J Physiol Pharmacol 91(10):839\u2013847","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"5167_CR161","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00133072","volume":"3","author":"S Vanderschueren","year":"1996","unstructured":"Vanderschueren S, Collen D, Van de Werf F (1996) Current clinical experience with staphylokinase in arterial thrombosis. J Thromb Thromb 3(4):297\u2013300","journal-title":"J Thromb Thromb"},{"issue":"3","key":"5167_CR162","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-8703(03)00312-0","volume":"146","author":"P Armstrong","year":"2003","unstructured":"Armstrong P, Burton J, Pakola S, Molhoek P, Betriu A, Tendera M et al (2003) Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS II). Am Heart J 146(3):484\u2013488","journal-title":"Am Heart J"},{"issue":"5","key":"5167_CR163","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0002-8703(00)90013-9","volume":"139","author":"PW Armstrong","year":"2000","unstructured":"Armstrong PW, Burton JR, Palisaitis D, Thompson CR, Ban de Werf F et al (2000) Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS). Am Heart J 139(5):820\u2013823","journal-title":"Am Heart J"},{"issue":"6","key":"5167_CR164","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/01.CIR.87.6.1850","volume":"87","author":"D Collen","year":"1993","unstructured":"Collen D, Van de Werf F (1993) Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction. Circulation 87(6):1850\u20131853","journal-title":"Circulation"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-019-05167-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T17:16:51Z","timestamp":1611681411000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-019-05167-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5167"],"URL":"https:\/\/doi.org\/10.1007\/s11033-019-05167-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]},"assertion":[{"value":"21 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}